The British Journal of Psychiatry Reports "Significantly Robust"
Improvement in ADHD and Depression Symptoms, treatment was much more effective than placebo.
CALGARY, Jan. 30, 2014 /CNW/ - Researchers at the University of
Canterbury in Christchurch New Zealand have found in a double blind study that a nutritional supplement "Truehope EMPowerplus™" has significant benefits
for adults with psychiatric symptoms of ADHD, depression,
hyperactivity, impulsivity and inattention. Dr. Julia Rucklidge and her team of researchers successfully completed
the placebo-controlled study, which was published today in The British
Journal of Psychiatry.
In the study researchers reported "We demonstrated that micronutrient
treatment induced statistically robust improvements in several
indices…." "Specifically, participants taking the micronutrient formula
reported greater improvement in both inattention and hyperactivity/
impulsivity compared with those taking a placebo."
Dr. Rucklidge further reported "Hyperactivity/ impulsivity scores were
reduced into the normal non-clinical range with micronutrient
administration but not placebo."
The research publication also identified a major reduction in symptoms
of depression (using the MADRS depression rating scale) in those
suffering with moderate to severe depression. "A further exploration of
the MADRS scores revealed a significant difference favouring the
micronutrient group when a subsample of those with moderate or severe
depression at baseline was examined"
According to the researchers 47.6% of the micronutrient group were
"much" to "very much improved" over the eight-week study.
Anthony Stephan Founder of Truehope the producer of EMPowerplus™ stated
"This research now places Truehope EMPowerplus™ in a new class of first
line treatments for many of the most common mood disorders. The safety
profile of the product has been researched extensively and has been
proven to be safe in use over the past 16 years." Dr. Rucklidge states
in the publishing "These results are consistent with a review of over
140 patients treated with this micronutrient formula, which did not
identify any significant adverse effects or safety concerns"
The micronutrient formula known as Truehope EMPowerplus™, was developed
by The Synergy Group of Canada Inc., an Alberta-based organization
dedicated to researching and developing new cutting edge technologies
for the treatment of mood disorders. Truehope EMPowerplus™ has been the
subject of twenty-four medical journal publications of which two are
double blind placebo controlled studies. For more information about the
supplement go to www.truehope.com or call 1-888-TRUEHOPE
SOURCE: Truehope Nutritional Support Ltd.
For further information:
Media interviews contact Anthony Stephan 403-634-8772